Free tool
FAERS Monitor: Augmentin Es-600
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 050755 or its brand name (Augmentin Es-600, Amoxicillin, Clavulanate Potassium). Reports on generic versions are filed under their own applications.
Reports
4,551
Serious
3,751
82% of reports
Hospitalization
2,023
Death reported
433
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- diarrhoea384
- dyspnoea357
- pyrexia265
- drug ineffective253
- nausea244
- fatigue239
- pruritus230
- vomiting229
- pneumonia227
- rash226
- pain215
- headache197
- cough190
- asthma179
- condition aggravated178
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 206 |
| 2005 | 149 |
| 2006 | 55 |
| 2007 | 55 |
| 2008 | 72 |
| 2009 | 307 |
| 2010 | 376 |
| 2011 | 452 |
| 2012 | 393 |
| 2013 | 9 |
| 2014 | 59 |
| 2015 | 143 |
| 2016 | 206 |
| 2017 | 207 |
| 2018 | 327 |
| 2019 | 262 |
| 2020 | 237 |
| 2021 | 167 |
| 2022 | 173 |
| 2023 | 170 |
| 2024 | 206 |
| 2025 | 196 |
| 2026 | 123 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,608 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| asthmaSignal | 179 | 7.3 | 6.3 | 976 |
| pyrexiaSignal | 265 | 3.5 | 3.2 | 488 |
| pneumoniaSignal | 227 | 3.2 | 2.9 | 355 |
| coughSignal | 190 | 3.1 | 2.7 | 277 |
| dyspnoeaSignal | 357 | 2.9 | 2.6 | 460 |
| pruritusSignal | 230 | 2.8 | 2.4 | 262 |
| diarrhoeaSignal | 384 | 2.8 | 2.5 | 439 |
| condition aggravatedSignal | 178 | 2.7 | 2.3 | 193 |
| rashSignal | 226 | 2.4 | 2.1 | 186 |
| vomitingSignal | 229 | 2.3 | 2.0 | 162 |
| pain | 215 | 1.6 | 1.4 | 52 |
| headache | 197 | 1.5 | 1.3 | 28 |
| nausea | 244 | 1.4 | 1.3 | 32 |
| fatigue | 239 | 1.4 | 1.3 | 30 |
| drug ineffective | 253 | 0.9 | 0.8 | 4 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.